1.Application and Value of Authentication Methods in the Study on Traditional Chinese Medicine Classics
Lufeng ZHENG ; Zheng GE ; Xiang LI ; Guangkun CHEN ; Fanglin HU ; Yanhong YANG ; Hongtao LI
Journal of Traditional Chinese Medicine 2026;67(4):349-354
This paper systematically reviewed the concept of authentication studies on traditional Chinese medicine (TCM) classics and the research achievements of scholars across historical and contemporary periods. We categorized the authentication studies on TCM classics into four types, including work-oriented authentication research, metho-dological studies on authentication, extended authentication research, and single-book authentication. Multiple methods were applied comprehensively, including investigating bibliographic documents of successive dynasties, analyzing the academic contents of medical books, studying the textual characteristics of medical books, examining the cited references in medical books, verifying the biographies of authors, and analyzing the interpolations and accretions in medical books, to distinguish the authenticity of TCM classics. The academic value of authenticity identification of TCM classics is concluded in three aspects,i.e. it serves as an important means to distinguish authenticity from falsehood in TCM classics, an important guarantee for inheriting the essence of TCM literature, and a key to unlocking the academic treasure trove of TCM classics and achieving inheritance-based innovation, which will lay a solid documentary foundation for constructing identification methodologies and standardized systems.
2.Construction of myeloid specific nuclear factor ⅠB conditional gene knockout mice and its intestinal inflammation manifestation
Manqiu HU ; Li ZHOU ; Siyuan CHEN ; Hongtao LIU ; Hao ZHANG ; Song HE ; Zhihang ZHOU
Academic Journal of Naval Medical University 2025;46(2):215-222
Objective To investigate the relationship between the expression of nuclear factor ⅠB(NFⅠB)in myeloid cells and intestinal inflammation by constructing NFⅠB conditional gene knockout(cKO)mice.Methods Human Protein Atlas database,Genotype-Tissue Expression database,and FANTOM5 database were used to investigate the expression of NFⅠB in inflammatory cells.NFⅠB-floxed mice were constructed using CRISPR/Cas9 technology and hybridized with LyZ2-Cre transgenic mice.Myeloid specific NFⅠB cKO mice(NFⅠBfl/flLyz2-Cre)were obtained by self-crossing the progeny.After the genotype identification of mice by agarose gel electrophoresis,4 NFⅠB cKO mice of C57BL/6N strain were selected as experimental group,and 4 non-cKO mice were selected as control group.Both groups were induced with 2.5%dextran sulfate sodium salt(DSS)under the same condition to establish a chronic colitis model,and the severity of colitis was evaluated by clinical manifestations and histopathology.Results Analysis showed that NFⅠB was expressed in both myeloid granulocytes and monocytes,and the highest expression was found in neutrophils.NFⅠB cKO mice were successfully constructed using CRISPR/Cas9 technology and Cre-loxP system.DSS-induced enteritis NFⅠB cKO mice developed diarrhea,gross blood stools,reduced activity,and weight loss in a short time.The gross examination of the intestines showed that the colon of the NFⅠB cKO mice was significantly shorter than that of the non-cKO mice([8.23±0.35]cm vs[10.30±0.36]cm,P<0.01).Intestinal H-E staining showed changes in mucosal glandular structure and connective tissue hyperplasia with extensive inflammatory cell infiltration in NFⅠB cKO mice.The histological score of NFⅠB cKO mice was significantly higher than that of non-cKO mice(4.25±0.50 vs 0.50±0.58,P<0.01).Intestinal immunohistochemical staining showed that more CD11b positive cells were recruited in NFⅠB cKO mice than non-cKO mice.Conclusion Myeloid specific NFⅠB cKO mice have been successfully constructed,and NFⅠB in myeloid cells can reduce infiltration of immune cells(granulocytes or/and monocytes)to inhibit intestinal inflammation.
3.Tubeless subxiphoid uniportal video-assisted thoracoscopic surgery with percutaneous suspension technique via balance-shaped sternal elevation device in anterior mediastinal masses
Junmin ZHU ; Junjie WANG ; Jianming YUE ; Yixin SUN ; Yichen LIU ; Lei WANG ; Lin LIN ; Jie LI ; Jinlan ZHAO ; Xuehua TU ; Ningying DING ; Jianrong HU ; Chunmei HE ; Leilei TIAN ; Hongtao TANG ; Jiasheng ZHAO ; Cheng CHEN ; Yongxiang SONG ; Yunwei TIAN ; Yong XIAO ; Kaidi LI ; Lin MA ; Yun WANG ; Longqi CHEN ; Dong TIAN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(11):1603-1609
Objective To assess the clinical value of a novel surgical technique—Tubeless subxiphoid uniportal video-assisted thoracoscopic surgery with percutaneous suspension technique via balance-shaped sternal elevation device in the resection of anterior mediastinal masses. Methods Patients who underwent tubeless subxiphoid uniportal video-assisted thoracoscopic surgery via balance-shaped sternal elevation device in anterior mediastinal masses process at the Department of Thoracic Surgery, West China Hospital, Sichuan University from March to April 2025 were included, and their clinical data were analyzed. Results A total of 4 patients were included, with 2 males and 2 females, aged 58-75 years. The diameter of the tumor was 2.5-3.0 cm. The operation time was 60.0-150.0 min, intraoperative blood loss was 5-10 mL, pain score on the 3rd day after surgery was 0 points, and postoperative hospital stay was 2-3 days. All patients achieved complete resection of the masses and thymus without perioperative complications. Conclusion The tubeless subxiphoid uniportal video-assisted thoracoscopic surgery with percutaneous suspension technique via balance-shaped sternal elevation device technique optimizes surgical visualization and instrument maneuverability while avoiding complications related to conventional anesthesia and tubing, thereby markedly enhancing the minimally invasive profile of anterior mediastinal masses resections. In addition to maintaining procedural safety, this approach effectively reduces postoperative pain and accelerates patient recovery, highlighting its potential for widespread clinical adoption.
4.Arterial embolization combined with local ablation for the treatment of recurrent and refractory chest wall tumors
Quanjun YAO ; Hongtao HU ; Hailiang LI ; Chenyang GUO ; Ke ZHAO ; Yanan ZHAO ; Weili XIA ; Yanan LI
Journal of Interventional Radiology 2024;33(2):135-139
Objective To discuss the safety and efficacy of arterial embolization combined with local ablation in the treatment of recurrent and refractory chest wall tumors.Methods The clinical data of 11 patients with chest wall tumor that recurred after surgery and progressed after treatment were retrospectively analyzed.On the basis of the original treatment regimen,DSA-guided arterial embolization and CT-guided local ablation were employed.VAS score of pain relief and postoperative complications were recorded,and the therapeutic efficacy was evaluated Results All the patients were follow up for a median time of 18.5 months.Successful DSA-guided arterial embolization was accomplished in all patients.Seven patients(9 lesions in total)initially received CT-guided radiofrequency ablation(RFA),and tumor reoccurred in 2 patients,who had to receive RFA once more.Four patients(5 lesions in total)initially received CT-guided microwave ablation(MWA),and tumor reoccurred in one patient,who had to receive MWA again.According to mRECIST criteria,the 6-month,12-month and 18-month objective response rates(ORR)were 72.7%(8/11),45.5%(5/11)and 18.2%(2/11)respectively,the 6-month,12-month and 18-month overall survival rates were 81.8%(9/11),63.6%(7/11)and 27.3%(3/11)respectively,with a median survival time of 13.2 months.The postoperative one-month and 3-month VAS scores were(2.42±1.25)points and(1.91±1.24)points respectively,which were strikingly lower than preoperative(6.78±1.13)points,the differences were statistically significant(P<0.05).After surgery,3 patients developed pleural effusion,which disappeared after puncture and drainage treatment,and 2 patients developed fever,which was improved after symptomatic treatment.One patient died of respiratory failure six months after treatment.Conclusion Arterial embolization combined with local ablation can improve the symptoms of pain and prolong the survival time of patients with chest wall tumors.This combination therapy is less traumatic and clinically safe,and it can be used as an effective treatment for patients with recurrent and refractory chest wall tumors.
5.Design of an improved percutaneous transhepatic cholangio drainage tube based on MRCP imaging data
Xiang GENG ; Hailiang LI ; Hongtao HU ; Chenyang GUO ; Hongkai ZHANG ; Jing LI ; Quanjun YAO ; Weili XIA ; Hang YUAN
Chinese Journal of Internal Medicine 2024;63(3):291-294
Objective:Quantified MRCP imaging data was used as a reference for design and preparation of a modified percutaneous transhepatic cholangio drainage (PTCD) tube.Methods:3.0 T upper abdominal MR and MRCP imaging data of 2 300 patients treated from July 2015 to July 2020 at the Department of Radiology of the Affiliated Cancer Hospital of Zhengzhou University were screened and a total of 381 patients diagnosed with biliary duct structures were identified. Causative etiologies among these patients included pancreatic adenocarcinoma (pancreatic head), cholangiocarcinoma, ampullary carcinoma, as well as intrahepatic and/or extrahepatic bile duct dilation. An improved PTCD tube was designed based on MRCP quantification of left and right hepatic and common hepatic duct length.Results:In the setting of biliary obstruction caused by malignancy, the distance of the left hepatic duct from its origin to the point of left and right hepatic duct confluence was 15.9±3.8 mm, while the distance of the right hepatic duct from its origin to the point of left and right hepatic duct confluence was 12.4±3.2 mm; the length of the bile duct from its origin to the point of left and right hepatic duct confluence was 34.0±8.1 mm. The improved PTCD tube design incorporated an altered length of the drainage orifice.Conclusion:MRCP imaging of the biliary tract is effective for measuring biliary tract length in the setting of pathological dilation. Based on our biliary tract measurements, a modified PTCD tube was designed to more effectively meet drainage requirements and manage biliary obstruction caused by Bismuth-Corlette type Ⅱ and Ⅲ malignancies.
6.Research progress of autophagy in fibrotic diseases
Ping NIE ; Hu LI ; Hongtao ZHU ; Jianguo HU
Chongqing Medicine 2024;53(9):1406-1411
Fibrosis is a common pathological change in clinical end-stage diseases,which can occur in any organ and is also a major burden of global health care.Persistent fibrosis can lead to organ failure and seri-ously threaten the life and health of patients,but its mechanism is still unclear.With the deepening of the re-search on fibrosis in modern science,the application of single cell genomics has brought new insights into the exploration of fibrosis tissue biology and disease mechanism in clinic.Since the discovery of autophagy,more and more studies at home and abroad have confirmed that autophagy is involved in the occurrence and develop-ment of fibrosis,which provides a new direction for the treatment of organ fibrosis.This article summarizes the effects of autophagy on organs such as lung and uterus,and summarizes the research progress of autoph-agy pathway in organ fibrosis in recent years,in order to provide new ideas for the treatment of organ fibrosis.
7.Effect of distal clavicle anatomical locking plate internal fixation combined with coracoclavicular ligament reconstruction in the treatment of old Neer type Ⅱb distal clavicle fractures
Hongtao CHEN ; Jun QU ; Runwu HU
Journal of Xinxiang Medical College 2024;41(10):935-940
Objective To investigate the clinical effect of distal clavicle anatomical locking plate internal fixation com-bined with coracoclavicular ligament reconstruction in the treatment of old Neer type Ⅱb distal clavicle fractures.Methods Ninety-five patients with old Neer type Ⅱb distal clavicle fractures admitted to the Department of Emergency Trauma Surgery,Nanyang First People's Hospital from February 2019 to January 2022 were selected as the research subjects,and the patients were divided into a control group(n=50)and an observation group(n=45)according to the surgical protocols.The patients in the control group received distal clavicle anatomical locking plate internal fixation,while the patients in the observation group received distal clavicle anatomical locking plate internal fixation combined with coracoclavicular ligament reconstruction.The fracture healing time of patients in the two groups was calculated based on the criteria of blurred fracture line under X-ray,continuity of bone scab passing through the fracture line,and the absence of pain on percussion and pressure;at the final follow-up,the functional recovery of the shoulder joint was evaluated according to Herscovici efficacy criteria to calculate the overall excellent rate;before operation,at 6 months after operation,and at 12 months after operation,the subjective pain of patients in the resting state was evaluated by using the visual analogue scale(VAS),the shoulder joint function of patients in the resting state was evaluated by using the Constant-Murley scale,and the coracoclavicular distance,acromioclavicular distance,forward flexion mobility,and external rotation mobility of patients were determined by using the spiral CT.The perioperative complications such as superficial incision infection,distal fracture displacement,shoulder joint pain,vascular nerve injury,re-fracture,and bone infection were compared between the two groups.Results The absorption time of absorbable sutures of patients in the observation group was(4.12±1.28)weeks.The fracture healing time of patients in the observation group was significantly shorter than that in the control group(t=5.558,P<0.05).The overall excellent rate of shoulder joint function recovery of patients in the observation group was significantly higher than that in the control group(x2=4.222,P<0.05).Before operation,there was no statistically significant difference in the VAS score and Constant-Murley score of patients between the control group and the observation group(P>0.05);at 6 and 12 months after operation,the VAS scores of the patients in the two groups were significantly lower than those before operation,while the Constant-Murley scores were signifi-cantly higher than those before operation(P<0.05);the VAS scores of patients in the two groups at 12 months after operation were significantly lower than those at 6 months after operation,while the Constant-Murley scores were significantly higher than those at 6 months after operation(P<0.05);at 6 and 12 months after operation,the VAS scores of patients in the observation group were significantly lower than those in the control group,while the Constant-Murley scores were significantly higher than those in the control group(P<0.05).Before operation,there was no statistically significant difference in coracoclavicular distance,acromioclavicular distance,forward flexion mobility,and external rotation mobility between the control group and the observation group(P>0.05);at 6 and 12 months after operation,the coracoclavicular distance and acromioclavicular distance of patients in the two groups were significantly smaller than those before operation,while the forward flexion mobility and external rotation mobility were significantly greater than those before operation(P<0.05);the coracoclavicular distance and acromio-clavicular distance of patients in the two groups at 12 months after operation were significantly smaller than those at 6 months after operation,while the forward flexion mobility and external rotation mobility were significantly greater than those at 6 months after operation(P<0.05);at 6 and 12 months after operation,the coracoclavicular distance and acromioclavicular distance of patients in the observation group were significantly smaller than those in the control group,while the forward flexion mobility and external rotation mobility were significantly greater than those in the control group(P<0.05).There were no perioperative complications in patients in the two groups,such as vascular nerve injury,re-fracture,and bone infection.The total complication rates of patients in the control group and the observation group were 6.00%(3/50)and 6.67%(3/45),respectively;there was no statistically significant difference in total complication rates of patients between the control group and the observation group(x2=0.084,P>0.05).Conclusion Distal clavicle anatomical locking plate internal fixation combined with coracocla-vicular ligament reconstruction has a significant effect in the treatment of old Neer type Ⅱb distal clavicle fractures,which can quicken fracture healing,reduce pain,and improve shoulder joint function and the three-dimensional morphology of the acromiocla-vicular joint,with few complications.
8.Spatially resolved metabolomics visualizes heterogeneous distribution of metabolites in lung tissue and the anti-pulmonary fibrosis effect of Prismatomeris connate extract
Jiang HAIYAN ; Zheng BOWEN ; Hu GUANG ; Kuang LIAN ; Zhou TIANYU ; Li SIZHENG ; Chen XINYI ; Li CHUANGJUN ; Zhang DONGMING ; Zhang JINLAN ; Yang ZENGYAN ; He JIUMING ; Jin HONGTAO
Journal of Pharmaceutical Analysis 2024;14(9):1330-1346
Pulmonary fibrosis(PF)is a chronic progressive end-stage lung disease.However,the mechanisms un-derlying the progression of this disease remain elusive.Presently,clinically employed drugs are scarce for the treatment of PF.Hence,there is an urgent need for developing novel drugs to address such diseases.Our study found for the first time that a natural source of Prismatomeris connata Y.Z.Ruan(Huang Gen,HG)ethyl acetate extract(HG-2)had a significant anti-PF effect by inhibiting the expression of the transforming growth factor beta 1/suppressor of mothers against decapentaplegic(TGF-β1/Smad)pathway.Network pharmacological analysis suggested that HG-2 had effects on tyrosine kinase phosphorylation,cellular response to reactive oxygen species,and extracellular matrix(ECM)disassembly.Moreover,mass spec-trometry imaging(MSI)was used to visualize the heterogeneous distribution of endogenous metabolites in lung tissue and reveal the anti-PF metabolic mechanism of HG-2,which was related to arginine biosyn-thesis and alanine,asparate and glutamate metabolism,the downregulation of arachidonic acid meta-bolism,and the upregulation of glycerophospholipid metabolism.In conclusion,we elaborated on the relationship between metabolite distribution and the progression of PF,constructed the regulatory metabolic network of HG-2,and discovered the multi-target therapeutic effect of HG-2,which might be conducive to the development of new drugs for PF.
9.Clinical report and genetic analysis of a child with Aicardi-Goutières syndrome type 3 due to compound heterozygous variants of RNASEH2C gene.
Juan LIU ; Jihong HU ; Rong QIN ; Yaqin DUAN ; Hongtao ZHOU ; Yujuan XIONG
Chinese Journal of Medical Genetics 2023;40(1):81-86
OBJECTIVE:
To explore the clinical characteristics and genetic etiology of a child with Aicardi-Goutières syndrome 3 (AGS3).
METHODS:
Trio whole exome sequencing was carried out for the child and his parents, and candidate variants were verified by Sanger sequencing. To further clarify their pathogenicity, the crystal structure of the variants was simulated and analyzed, and the plasmid of variants was expressed in vitro. A literature search was also carried out to summarize the phenotypic and genetic characteristics of AGS3.
RESULTS:
The child was found to harbor novel compound heterozygous variants of the RNASEH2C gene, namely c.434G>T (p.Arg145Leu) and c.494G>C (p.Ter165Ser), which were inherited from his mother and father, respectively. Analysis of protein crystal structure suggested that the c.434G>T (p.Arg145Leu) variant may affect the stability of local structure, and in vitro experiments showed that this variant can lead to protein degradation. The c.494G>C (p.Ter165Ser) variant has destroyed the stop codon, resulting in prolonged variant.
CONCLUSION
The novel compound heterozygous variants of the RNASEH2C gene probably underlay the AGS3 in this child, which has enriched the phenotypic and mutational spectrum of this disorder.
Humans
;
Child
;
Mutation
;
Autoimmune Diseases of the Nervous System/genetics*
;
Nervous System Malformations/genetics*
10.Efficacy and safety of parecoxib versus ketorolac tromethamine for perioperative analgesia:a systematic review
Mao LIN ; Zhiqiang HU ; Ya CHEN ; Hongtao XIAO ; Qian JIANG
China Pharmacy 2023;34(4):476-481
OBJECTIVE To compare the efficacy and safety of parecoxib and ketorolac tromethamine for perioperative analgesia, and to provide evidence-based reference for clinical drug use. METHODS Retrieved from PubMed, Embase, the Cochrane Library, CNKI, VIP, Wanfang Data, Baidu and Google, randomized controlled trials (RCT) about parecoxib (trial group) versus ketorolac tromethamine (control group) for perioperative analgesia were collected from the inception to Jun. 17th, 2022. After screening the literature and extracting the data, the quality of the included literature was evaluated using the bias risk assessment tool recommended by Cochrane system evaluator manual 5.1.0. Meta-analysis, sensitivity analysis and publication bias analysis were performed with RevMan 5.4 software. RESULTS A total of 12 RCTs were included, with 1 118 patients. Meta- analysis results showed that at the time of administration before anesthesia induction, there was no statistically significant difference between the 2 groups in visual analogue scale (VAS) [MD=-0.16, 95%CI (-0.41, 0.09), P=0.20], numerical rating scale (NRS) [MD=0.01, 95%CI (-0.36, 0.38), P=0.97], postoperative bleeding [MD=0.15, 95%CI (-0.63, 0.93), P=0.71], and consumption of opioid analgesics [MD=0.12, 95%CI (-0.77, 1.01), P=0.79]. At the time of postoperative administration, VAS and bleeding volume at 48 h after operation of trial group were significantly lower than control group (P<0.05). The results of subgroup analysis by different com assessment time points showed that the VAS of patients in trial group at 0 h after operation were significantly lower than control group at the time of administration before anesthesia induction; at the time of postoperative administration, VAS of patients in the trial group at 12 h and 48 h after operation were significantly lower than control group (P<0.05). There was no statistical significance in the incidence of ADR between 2 groups [RR=0.93,95%CI (0.78,1.11),P=0.43]. The results of subgroup analysis according to different types of adverse reactions showed that the incidence of nausea and vomiting of trial group was significantly lower than control group, and the incidence of other adverse reactions was significantly higher than control group (P<0.05). Results of sensitivity analysis showed that study results were stable and reliable. Results of publication bias analysis showed that there was great possibility of publication bias in this study. CONCLUSIONS The efficacy of parecoxib is equivalent to that of ketorolac tromethamine for perioperative analgesia before operation; at the time of administration after operation, parecoxib has better analgesic effect and less postoperative bleeding; the incidence of nausea and vomiting caused by parecoxib is lower at any time of administration.

Result Analysis
Print
Save
E-mail